Literature DB >> 25001589

Identification of featured biomarkers in different types of lung cancer with DNA microarray.

Chao Zhou1, Hao Chen, Li Han, An Wang, Liang-An Chen.   

Abstract

Lung cancer is a worldwide leading cause of cancer-related death. The aim of this study was to identify target genes and specific biomarkers for identification and treatment of different types of lung cancer with DNA microarray. Gene expression profile GSE6044 and miRNA microarray profile GSE17681 were downloaded from Gene Expression Omnibus database. The differentially expressed genes (DEGs) and miRNAs were screened with multtest package in R language. Then, functional enrichment analysis of identified DEGs was performed. Furthermore, the verified target genes based on screened miRNAs were selected from miRTarBase and miRecords databases. Then miRNA-target gene regulation network was constructed. APOE, CDC6 and ATP2B1were involved in most of the functions obtained for adenocarcinomas, small cell lung cancer and squamous cell carcinomas, respectively. The target DEGs of differentially expressed hsa-miR-29a included FGG in adenocarcinoma, RAN and COL4A1 in small cell lung cancer, GLUL in squamous cell carcinoma. The target DEGs of has-miR-7 were SNCA and SLC7A5 in adenocarcinoma and small cell lung cancer, respectively. ICAM1 and KIT were the target DEGs of hsa-miR-222 in adenocarcinoma and squamous cell carcinoma. The miRNAs and their differentially expressed target genes have the potential to be used in clinic for diagnosis and treatment of different kinds of lung cancer in the future.

Entities:  

Year:  2014        PMID: 25001589     DOI: 10.1007/s11033-014-3515-9

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  43 in total

Review 1.  Non-small cell lung cancer.

Authors:  David S Ettinger; Wallace Akerley; Gerold Bepler; Matthew G Blum; Andrew Chang; Richard T Cheney; Lucian R Chirieac; Thomas A D'Amico; Todd L Demmy; Apar Kishor P Ganti; Ramaswamy Govindan; Frederic W Grannis; Thierry Jahan; Mohammad Jahanzeb; David H Johnson; Anne Kessinger; Ritsuko Komaki; Feng-Ming Kong; Mark G Kris; Lee M Krug; Quynh-Thu Le; Inga T Lennes; Renato Martins; Janis O'Malley; Raymond U Osarogiagbon; Gregory A Otterson; Jyoti D Patel; Katherine M Pisters; Karen Reckamp; Gregory J Riely; Eric Rohren; George R Simon; Scott J Swanson; Douglas E Wood; Stephen C Yang
Journal:  J Natl Compr Canc Netw       Date:  2010-07       Impact factor: 11.908

Review 2.  Microarray data analysis: from disarray to consolidation and consensus.

Authors:  David B Allison; Xiangqin Cui; Grier P Page; Mahyar Sabripour
Journal:  Nat Rev Genet       Date:  2006-01       Impact factor: 53.242

Review 3.  Clinical practice. Lung cancer screening.

Authors:  James L Mulshine; Daniel C Sullivan
Journal:  N Engl J Med       Date:  2005-06-30       Impact factor: 91.245

4.  Apolipoprotein E expression promotes lung adenocarcinoma proliferation and migration and as a potential survival marker in lung cancer.

Authors:  Wen-Pin Su; Yen-Ting Chen; Wu-Wei Lai; Chien-Chung Lin; Jing-Jou Yan; Wu-Chou Su
Journal:  Lung Cancer       Date:  2011-01       Impact factor: 5.705

5.  Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer.

Authors:  Zhibin Hu; Xi Chen; Yang Zhao; Tian Tian; Guangfu Jin; Yongqian Shu; Yijiang Chen; Lin Xu; Ke Zen; Chenyu Zhang; Hongbing Shen
Journal:  J Clin Oncol       Date:  2010-03-01       Impact factor: 44.544

6.  TGF-beta IL-6 axis mediates selective and adaptive mechanisms of resistance to molecular targeted therapy in lung cancer.

Authors:  Zhan Yao; Silvia Fenoglio; Ding Cheng Gao; Matthew Camiolo; Brendon Stiles; Trine Lindsted; Michaela Schlederer; Chris Johns; Nasser Altorki; Vivek Mittal; Lukas Kenner; Raffaella Sordella
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-16       Impact factor: 11.205

Review 7.  Lung cancer screening.

Authors:  U Pastorino
Journal:  Br J Cancer       Date:  2010-04-27       Impact factor: 7.640

8.  The single nucleotide polymorphism g.1548A >G (K469E) of the ICAM-1 gene is associated with worse prognosis in non-small cell lung cancer.

Authors:  Eirini Thanopoulou; George Kotzamanis; Ioannis S Pateras; Nicholaos Ziras; Alexandros Papalambros; Theodoros Mariolis-Sapsakos; Fragiska Sigala; Elizabeth Johnson; Athanassios Kotsinas; Andreas Scorilas; Vassilis G Gorgoulis
Journal:  Tumour Biol       Date:  2012-05-06

9.  A miRNA-regulatory network explains how dysregulated miRNAs perturb oncogenic processes across diverse cancers.

Authors:  Christopher L Plaisier; Min Pan; Nitin S Baliga
Journal:  Genome Res       Date:  2012-06-28       Impact factor: 9.043

10.  Clinical validation of an autoantibody test for lung cancer.

Authors:  P Boyle; C J Chapman; S Holdenrieder; A Murray; C Robertson; W C Wood; P Maddison; G Healey; G H Fairley; A C Barnes; J F R Robertson
Journal:  Ann Oncol       Date:  2010-07-30       Impact factor: 32.976

View more
  6 in total

1.  Multiple functional linear model for association analysis of RNA-seq with imaging.

Authors:  Junhai Jiang; Nan Lin; Shicheng Guo; Jinyun Chen; Momiao Xiong
Journal:  Quant Biol       Date:  2015-08-15

2.  Role of microRNA-4458 in patients with non-small-cell lung cancer.

Authors:  Lidao Bao; Linlin Wang; Guomin Wei; Yuehong Wang; Gerile Wuyun; Agula Bo
Journal:  Oncol Lett       Date:  2016-09-22       Impact factor: 2.967

Review 3.  MicroRNA-7: a promising new target in cancer therapy.

Authors:  Juanjuan Zhao; Yijing Tao; Ya Zhou; Nalin Qin; Chao Chen; Dan Tian; Lin Xu
Journal:  Cancer Cell Int       Date:  2015-10-29       Impact factor: 5.722

4.  Bioinformatics analysis of gene expression alterations in microRNA‑122 knockout mice with hepatocellular carcinoma.

Authors:  Bosheng He; Ying He; Weixiang Shi; Shenchu Gong; Xiaohong Chen; Jing Xiao; Jinhua Gu; Wenbin Ding; Yilang Wang
Journal:  Mol Med Rep       Date:  2017-04-07       Impact factor: 2.952

Review 5.  The associations between Parkinson's disease and cancer: the plot thickens.

Authors:  Danielle D Feng; Waijiao Cai; Xiqun Chen
Journal:  Transl Neurodegener       Date:  2015-10-26       Impact factor: 8.014

6.  Integrated quantitative proteomic and transcriptomic analysis of lung tumor and control tissue: a lung cancer showcase.

Authors:  Stefan Tenzer; Petra Leidinger; Christina Backes; Hanno Huwer; Andreas Hildebrandt; Hans-Peter Lenhof; Tanja Wesse; Andre Franke; Eckart Meese; Andreas Keller
Journal:  Oncotarget       Date:  2016-03-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.